Product

KAIVEXIN- 300

Route of administration

Subcutaneous

Composition - Each Multidose cartridge contains:

  • Enoxaparin Sodium I.P…..... 300 mg/3mL

  • (Porcine derived)

  • Phenol I.P……..........................0.25% w/v

  • (As Preservative)

  • Water For Injections I.P…................... q.s.

Indications

  • The prophylaxis of thromboembolic disorders of venous origin, in particular those which may be associated with orthopaedic or general surgery.

    • The prophylaxis of venous thromboembolism in medical patients bedridden due to acute illnesses including cardiac insufficiency, respiratory failure, or severe infections.

    • The treatment of venous thromboembolic disease presenting with deep vein thrombosis, pulmonary embolism or both.

    • The treatment of unstable angina and non-Q-wave myocardial infarction administered concurrently with aspirin.

    • Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI). The pre-vention of thrombus formation in the extracorporeal circulation during haemodialysis.